Histiocyte Society (HS)

The Histiocyte Society is a nonprofit organization of more than 200 physicians and scientists from around the world committed to improving the lives of patients with histiocytic disorders by conducting clinical and laboratory research into the causes and treatment of this disease.

On May 16, 1985, an historical international workshop convened in Philadelphia, initiated by Dr. Giulio D’Angio from the University of Pennsylvania Hospital, and led to the foundation of the Histiocyte Society. Participants numbered 15 at this inaugural meeting; membership has subsequently grown to approximately 220 scientists, physicians and nurses. This international society has provided a forum for the exchange of information and a framework for organized activities of fundamental importance.

Mission:
To advance knowledge about and improve outcomes for patients with histiocytic disorders through clinical and basic research and education.

Vision:
To be the worldwide leaders in understanding histiocytic disorders and improving outcomes.
Goals:
The Histiocyte Society has several goals in place that we work toward together on a daily basis. Those goals include:
• To improve the scientific understanding of the histiocytic disorders and translate this knowledge to improved care and treatments for patients with these disorders.
• To provide a forum to promote, facilitate and conduct research in histiocytic disorders.
• To educate physicians, scientists, and other healthcare professionals on the biology, etiology, diagnosis and treatment of histiocytic disorders.
• To partner with and advise lay organizations in educational and other matters concerning the histiocytic disorders.